Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew M Hutmacher

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Plos One|September 17, 2013
Predicting relapsing-remitting dynamics in multiple sclerosis using discrete distribution models: a population approachNieves Velez de Mendizabal, Matthew M Hutmacher, Iñaki F Troconiz, et al.
Arthritis Research & Therapy|July 27, 2014
Changes in serum creatinine in patients with active rheumatoid arthritis treated with tofacitinib: results from clinical trialsJohn D Isaacs, Andrea Zuckerman, Sriram Krishnaswami, et al.
Psychopharmacology|June 8, 2011
Translational PK-PD modelling of molecular target modulation for the AMPA receptor positive allosteric modulator Org 26576Roberta Bursi, Gul Erdemli, Robert Campbell, et al.
British Journal of Clinical Pharmacology|August 18, 2016
Comparative assessment of clinical response in patients with rheumatoid arthritis between PF-05280586, a proposed rituximab biosimilar, and rituximabJason H Williams, Matthew M Hutmacher, Matthew L Zierhut, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Plos One|September 17, 2013
Predicting relapsing-remitting dynamics in multiple sclerosis using discrete distribution models: a population approachNieves Velez de Mendizabal, Matthew M Hutmacher, Iñaki F Troconiz, et al.
Arthritis Research & Therapy|July 27, 2014
Changes in serum creatinine in patients with active rheumatoid arthritis treated with tofacitinib: results from clinical trialsJohn D Isaacs, Andrea Zuckerman, Sriram Krishnaswami, et al.
Psychopharmacology|June 8, 2011
Translational PK-PD modelling of molecular target modulation for the AMPA receptor positive allosteric modulator Org 26576Roberta Bursi, Gul Erdemli, Robert Campbell, et al.
British Journal of Clinical Pharmacology|August 18, 2016
Comparative assessment of clinical response in patients with rheumatoid arthritis between PF-05280586, a proposed rituximab biosimilar, and rituximabJason H Williams, Matthew M Hutmacher, Matthew L Zierhut, et al.
Pageof 3